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INTRODUCTION: A few cases of acute abdomen caused by perforation of small-intestinal gastrointestinal
stromal tumours (GISTs) have been reported in the literature.
PRESENTATIONOF CASE: Together with a review of the published cases, here we report a case of an elderly
patient with peritonitis due to spontaneous perforation of a GIST of the jejunum. An 82-year-old man
was admitted to the emergency unit of our hospital with fever and severe abdominal pain. An abdominal
enhanced computed tomography scan detected a 6 cm solid mass in the left upper quadrant adherent
to a jejunal loop and surrounded by free ﬂuid and free air. Due to the radiological features of the mass,
the diagnosis of a perforation of a GIST arising from the jejunum wall was suspected. The patient under-
went emergency laparotomy. Intraoperative ﬁndings conﬁrmed diffuse peritonitis secondary to jejunal
tumour perforation. A segmental resection of the jejunum containing the mass was performed followed
by a mechanical end-to-side anastomosis. The histopathologic examination of the mass conﬁrmed the
diagnosis of a perforated GIST of the small intestine (high-risk category). The post-operative course was
uneventful and the patient was treated with adjuvant imatinib therapy.
DISCUSSION: Twenty-one other cases of spontaneous perforation of small intestine GISTs are reported in
the literature and are summarized in the present review.
CONCLUSION: The described case is the tip of the iceberg and spontaneous rupture or perforation of GISTs
are a far more frequent ﬁrst presentation of this rare tumour.
© 2014 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Gastrointestinal stromal tumours (GISTs) are mesenchymal
neoplasms of the gastrointestinal tract (GI) that can arise anywhere
from the oesophagus to the rectum [1]. GISTs accounts for less than
1% of all GI tumours; however they are the most common mes-
enchymal neoplasms of the GI tract. Population-based studies from
different European countries report annual incidence rates ranging
Abbreviations: GIST(s), Gastrointestinal stromal tumours; GI, Gastrointestinal;
CT, Computed tomography; H&E, Hematoxylin and Eosin.
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from 6.5 to 20 cases per million [2–6]. These studies also report an
increase in the incidence of GISTs over the last two decades due to
the improvement in their diagnosis and registration [2,3].
Few GISTs manifest as abdominal emergencies, such as GI
haemorrhage, intestinal obstruction, or tumour perforation [7,8].
Although acute abdomen due to GIST perforation into the periton-
eal cavity is rare, a few cases of peritonitis caused by perforation of
small-intestinal GISTs have been reported in the literature [8–29].
Together with a review of the published cases, here we report a
case of an elderly patient with acute abdomen due to spontaneous
perforation of a GIST located in the jejunum.
2. Case presentation
An 82-year-old man was admitted to the emergency unit of
our hospital with fever, vomiting, diarrhoea and diffuse abdominal
pain that had been experienced for the previous 24h. The patient
http://dx.doi.org/10.1016/j.ijscr.2014.12.012
2210-2612/© 2014 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Fig. 1. Surgical specimen. The resected specimen includes the jejunal loop and the
perforatedGIST arising from the antimesenteric side of the loop. The arrow indicates
the ruptured margin of the tumour. The insert shows the histology of the specimen:
the perforation to the lumen of the jejunum is indicated by the arrow.
had a history of arterial hypertension. No other co-morbidities
were reported. Vital signs were within normal limits and the rec-
tal temperature was 38.6 ◦C. On examination, the abdomen was
distended with generalized tenderness and muscular defence. Lab-
oratory tests showedelevatedwhite cell count (13.430/mm3, 92.7%
neutrophils) and hyper-glycaemia (221mgdl−1).
Abdominal plain radiography showed gas-ﬂuid levels in the
small bowel without free intraperitoneal air. An abdominal
enhanced computed tomography (CT) scan was urgently per-
formed and revealed the presence of a 6×5.5×5.5 cm solidmass in
the left upperquadrant towards theumbilicus, adherent to a jejunal
loop, and surrounded by free ﬂuid. A small layer of free extralumi-
nal air was also seen close to the margin of the mass (Fig. 1). Due to
the radiological features of the mass, the diagnosis of a perforation
of a GIST located in the jejunum wall was suspected.
The patient underwent emergency laparotomy. Intraoperative
ﬁndings showed free purulent exudate in the abdominal cavity and
a diffuse inﬂammatory reaction of the peritoneum. The mass was
located10 cmaway from the Treitz ligament, on the antimesenteric
side of the ﬁrst jejunal loop (Fig. 2). The perforation was iden-
tiﬁed on the external border of the mass. A segmental resection
of the jejunum containing the mass was performed followed by a
mechanical end-to-side anastomosis, peritoneal irrigation and toi-
let, and ﬁnally the placement of multiple drainages. A search for
other gastrointestinal or peritoneal abnormalities was negative.
The post-operative course was uneventful and the patient was
discharged 10 days after surgery. On histological examination, the
specimen was described as a solid smooth grey and white mass
(maximum diameter of 7 cm) arising from the wall of the resected
segment of small bowel. H&E staining showed spindle-shaped cell
proliferation (Fig. 3a). The mitotic index was 16/50 high-power
ﬁeld (HPF) and the Ki-67 value was 15%. The immunohistochem-
ical staining was positive for C-KIT (Fig. 3b), focal positive for
h-caldesmon, negative for smooth muscle actin, desmin, CD34, S-
100, EMA and cytocheratine. All these ﬁndings led to the diagnosis
of GIST of the jejunum, which was classiﬁed as high-risk using the
prognostic classiﬁcation by Fletcher et al. [30]. The surgical mar-
gins were disease-free. As soon as the diagnosis was conﬁrmed by
histology, the patient was started on imatinib mesylate therapy at
the daily oral dose of 400mg and he is currently under follow-up
after six months of therapy.
3. Discussion
Nearly a third of patients with GISTs are asymptomatic and the
diagnosis is made incidentally during surgical, endoscopic, radio-
logic procedures or at autopsy [1,31]. Most of the symptomatic
patients present with vague, nonspeciﬁc abdominal pain or dis-
comfort, sometimes associated with nausea and vomiting. Patients
may also complain of early satiety or a sensation of abdominal
fullness. More frequently, GISTs larger than 4 cm may produce
symptoms secondary to obstruction or GI bleeding. The bleed-
ing can be either chronic, often leading to anaemia, or acute
with episodes of haematemesis or melena. Very few cases man-
ifest as other abdominal emergencies, such as haemoperitoneum
secondary to intra-abdominal tumour rupture, or peritonitis sec-
ondary to tumour perforation.
This latter emergency has been reported for all gastrointestinal
tracts [32–34]. However GIST perforation seems to occur more fre-
quently in the small bowel compared to other anatomic sites [35].
Our literature search revealed 21 cases of acute abdomen with dif-
fuse or localized peritonitis caused by spontaneous perforation of
small intestine GISTs (Table 1) [9–29]. Twomore cases are reported
in the case-series of Mansour and Coll [8]. They are not included in
Table 1 because the details of the cases are not available. In another
two cases not listed in Table 1, spontaneous ruptures of the small
intestinal GISTs were associated with an intraperitoneal abscess
without perforation to the intestinal lumen [35,36].
Of the 22 cases reported in Table 1, including this case, 16
patientsweremaleandﬁvewere female.GISTperforationcanoccur
irrespective of the age, since the patients’ ages ranged from 22 up
Fig. 2. Preoperative computed tomography (CT). (a) CT image showing air in the perforation track of the tumour (arrow); (b) CT image showing free air and intraperitoneal
free ﬂuid (arrow) around the jejunal tumour.
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Fig. 3. Histological ﬁndings. (a) H&E staining shows spindle-shaped cell proliferation; (b) immunoistochemical staining shows positivity for c-kit.
to 82 years. The jejunum was the more common location of per-
foration compared to the ileum (15 vs 4). In three other cases it
was not speciﬁed at what level of the small intestine the perfo-
rated GIST was located. These were all undiagnosed primary GISTs
tumours. In one patient the small intestinal GIST was associated
with hepatic metastases [9], in the other two cases small bowel
GISTs were multifocal [26,29]. In all the other 19 patients there
was a primary localized single GIST.
Diffuse peritonitis was described in 19 patients, while in the
remaining three the intraoperative presentation was a localized
abscess adjacent to the anatomical site of the perforated GIST.
Despiteperforationandconcomitantperitonitis, all authorsbutone
reported good post-operative outcome. The only death occurred on
postoperative day four due to septic shock in a complicated case of
perforated GIST of the ileum with concomitant small bowel necro-
sis secondary to internal herniation [16]. A possible explanation
of the very low morbidity and mortality in the reported cases is
the relatively low peritoneal contamination due to the predom-
inant proximal anatomic site of perforation, and the expeditious
resuscitation followed by emergency surgical intervention in all
patients with diffuse peritonitis. Primary small bowel anastomosis
was safely performed in all cases but one. The only exception was
a terminal ileostomy performed in the very compromised patient
reported by Özben et al. [16].
Complete surgical resection is considered the only potential
curative treatment for localized GISTs. However, the potential risk
of recurrence after surgery is consistent. Complete resection can
be achieved in approximately 85% of patients and the estimated
incidence of recurrence or metastasis after radical surgery is 50%
[31]. Using the widely accepted prognostic classiﬁcation proposed
by Fletcher et al. [30], based on the size of the tumour and the
mitotic count, GISTs are classiﬁed as very low-, low-, intermediate-
and high-risk for potential malignancy. Joensuu and Coll have pro-
posed a classiﬁcation that includes tumour rupture and tumour site
(Table 2) [37–39]. Based on this risk classiﬁcation, all the patients
with tumour rupture should be considered at high risk for recur-
rence [39,37].
Imatinib mesylate, a tyrosine kinase inhibitor, has been found
to be beneﬁcial after radical resective surgery of high-risk GISTs
[39,40]. More recently, adjuvant therapy with imitinab has been
used with wider indications, such as intermediate-risk tumours
with size >3 cm and primary tumours with rupture or perfora-
tion. [41,42]. Of the 21 surviving patients reported in Table 1, 13
were treated with imatinib, including our case. In the other eight
cases, there is no mention of imatinib therapy. Follow-up data are
reported for 12 patients, of which 10 were on imatinib adjuvant
therapy. All but one were alive without recurrence, with a follow-
up ranging from six to 48 months. The only exception was the case
Table 1
Summary of spontaneous perforated gastrointestinal stromal tumors (GISTs) of small intestine in the available medical literature.
First author (reference) Year Sex/age (years) Small-bowel location Size
(cm)
Mitotic counts Intraoperative
ﬁndings
Treatment Follow-up (months)
Yamamoto et al. [9] 2003 M/32 NR 15 28/50 Peritonitis SBR+ Imatinib 24 Alivea
Efremidou et al. [10] 2006 M/66 Ileum 7×5×4 2/50 Peritonitis SBR+ Imatinib 44 Alive
Karagülle et al. [11] 2008 M/70 Jejunum 5 NR Abscess SBR 13 Alive
Versaci et al. [12] 2009 M/46 Jejunum 12×7 5/50 Peritonitis SBR+ Imatinib 12 Alive
Taniguchi ey al. [13] 2009 M/59 NR 7,5 <5/50 Peritonitis SBR+ Imatinib 14 Alive
Licursi et al. [14] 2009 M/47 Jejunum 12,5×5 <5/50 Peritonitis SBR NR
Ku et al. [15] 2010 F/33 Jejunum 6.5×5×4 NR Peritonitis SBR NR
Özben et al. [16] 2010 M/65 Ileum 8×5 NR Peritonitis SBR+ Ileostomy Dead POD 4
Feng et al. [17] 2011 M/45 Jejunum 10×8 <5/50 Peritonitis SBR NR
Paramythiotis et al. [18] 2011 M/56 Jejunum 3 <5/50 Peritonitis SBR+ Imatinib 48 Alive
Bhandarwar et al. [19] 2011 F/55 Jejunum 36×15×10 5/50 Peritonitis SBR NR
Aslan et al. [20] 2012 F/50 Jejunum 13 NR Peritonitis SBR NR
Memmi et al. [21] 2012 M/59 Jejunum 12 7/50 Peritonitis SBR NR
Choudhary et al. [22] 2012 M/35 Jejunum 4,5×3,5×2,5 >5/10 Peritonitis SBR 48 Alive
Sezer et al. [23] 2012 F/61 Jejunum 5×2 9/50 Peritonitis SBR+ Imatinib 6 Alive
Roy et al. [24] 2012 M/46 Jejunum 3×2 NR Peritonitis SBR+ Imatinib 6 Alive
Shoji et al. [25] 2013 M/61 Jejunum 9×7 0/50 Peritonitis SBR+ Imatinib 36 Alive
Beltrán et al. [26] 2013 M/46 Ileum 7.5×7 15/50 Abscess SBR+ Imatinib NR
Misawa et al. [27] 2014 M/70 Jejunum 9×9 NR Abscess SBR+ Imatinib 12 Alive
Sharma et al. [28] 2014 F/50 Ileum 10×8 NR Peritonitis SBR+ Imatinib NR
Mansoor [29] 2014 M/41 Multiple NR NR Peritonitis SBR+ Imatinib NR
Present case 2014 M/82 Jejunum 7×5 16/50 Peritonitis SBR+ Imatinib 6 Alive
Legend: SBR=Small Bowel Resection; NR=Not Reported.
a Patient with metastatic disease at presentation.
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Table 2
Deﬁnition of the risk categories in the Joensuu classiﬁcation (39).
Risk category Tumor size (cm) Mitotic index
(per 50HPF*)
Primary tumor site
Very low risk ≤ 2.0 ≤ 5 Any
Low risk 2.1 –5.0 ≤ 5 Any
Intermediate risk ≤ 5.0 6–10 Gastric
5.1 –10.0 ≤ 5 Gastric
High risk Any Any Tumor rupture
> 10.0 Any Any
Any > 10 Any
> 5.0 > 5 Any
≤ 5.0 > 5 Non-gastric
5.1 –10.0 ≤ 5 Non-gastric
* HPF, high-power ﬁeld
reported by Yamamoto and Coll. This patient had multiple hepatic
metastases at the time of surgery and later developed peritoneal
dissemination. At that time (2001) imatinib was still an investiga-
tional chemiotherapic agent and the patient was treated with this
experimental therapy with dramatic clinical improvement [9].
4. Conclusions
Emergency presentation with a GIST is not uncommon and one
of its manifestations is acute abdomen secondary to intraperi-
toneal rupture or perforation of a primary GIST of the small
intestine. Emergency surgery ismandatory and should achieve rad-
ical resection. Primary anastomosis has been reported to be safe.
Since there is an increased risk of recurrence after spontaneous
intraperitoneal rupture/perforation of GISTs, patients should be
evaluated by a multidisciplinary team in order to assess the indi-
cations for imatinib adjuvant therapy and for close monitoring and
follow-up.
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